Alzheimer’s disease

Alzheimer’s disease is a progressive neurologic disorder that is the most common cause of dementia—a continuous decline in thinking, behavioral, and social skills that affects a person’s ability to function independently. It accounts for 60–80 % of dementia cases.

The disease is characterized by the abnormal buildup of proteins in and around brain cells: amyloid plaques outside cells and tau tangles inside cells. These changes lead to the death of neurons and the progressive shrinkage of the brain. Symptoms usually begin in the mid-60s or later (late-onset Alzheimer’s), although a rarer early-onset form can appear in the 30s to mid-60s.

There is currently no cure, but treatments can temporarily slow the worsening of symptoms in some people and improve quality of life. Research into disease-modifying therapies is advancing rapidly. Early diagnosis allows patients and families to plan for the future, participate in clinical trials, and access available therapies and support services.

Alzheimer’s disease progresses through stages, although the rate varies widely among individuals.

Early stage (mild)

• Memory loss that disrupts daily life—especially recently learned information or important dates
• Difficulty planning or solving problems
• Trouble completing familiar tasks at home or work
• Confusion with time or place
• Problems with words in speaking or writing
• Misplacing things and losing the ability to retrace steps
• Decreased or poor judgment
• Withdrawal from work or social activities
• Changes in mood or personality

Middle stage (moderate)
Memory and thinking problems become more obvious. Individuals may need help with daily activities, become confused about where they are or what day it is, show personality and behavioral changes (including suspicion or agitation), and have trouble controlling bladder or bowels.

Late stage (severe)
People lose the ability to respond to their environment, carry on a conversation, and eventually control movement. They need full-time assistance with daily personal care and become vulnerable to infections, especially pneumonia.

Memory loss is the most recognized symptom, but language, visuospatial skills, and executive function are also affected early.

The precise cause of Alzheimer’s disease is not fully understood, but it involves a combination of genetic, lifestyle, and environmental factors that affect the brain over time. At the pathologic level, two proteins are central:

• Beta-amyloid — Fragments of this protein clump into plaques that disrupt cell-to-cell communication and trigger immune responses that destroy neurons.
• Tau — Changes in the tau protein cause it to form neurofibrillary tangles that block the transport of nutrients and other essential molecules inside neurons.

These changes begin years before symptoms appear. In late-onset Alzheimer’s, the most common form, the strongest genetic risk factor is the APOE ε4 allele, but carrying it does not guarantee disease. Rare genetic mutations cause the early-onset familial form. Age remains the greatest overall risk factor.

Factors that increase the risk of developing Alzheimer’s disease include:

• Age — Risk doubles approximately every five years after age 65
• Family history and genetics — First-degree relatives have higher risk; APOE ε4 increases risk and lowers age of onset
• Down syndrome — Nearly all people with Down syndrome develop Alzheimer’s pathology by middle age
• Sex — Women appear to have a slightly higher risk, partly because they live longer
• Mild cognitive impairment — Increases the likelihood of progressing to dementia
• Cardiovascular risk factors — High blood pressure, high cholesterol, obesity, diabetes, and smoking in midlife
• Low education or cognitive engagement — Lower lifelong cognitive reserve
• Head trauma — Moderate to severe traumatic brain injury
• Sleep disorders — Chronic poor sleep or sleep apnea
• Social isolation and depression

As Alzheimer’s progresses, it leads to:

• Loss of independence and need for full-time care
• Increased risk of falls and injuries
• Malnutrition and dehydration
• Pneumonia and other infections (common ultimate cause of death)
• Blood clots and pressure sores from immobility
• Severe behavioral and psychological symptoms that distress both patients and caregivers

Caregiver burden is substantial and can lead to depression, physical illness, and financial strain. Planning for progressive care needs is an essential part of management.

While there is no proven way to prevent Alzheimer’s disease, growing evidence supports several strategies that may reduce risk or delay onset:

• Control cardiovascular risk factors—manage blood pressure, cholesterol, blood sugar, and weight
• Stay physically active; regular aerobic and strength exercise benefits brain health
• Engage in cognitively stimulating activities and lifelong learning
• Maintain social connections
• Protect against head injury (seat belts, helmets, fall prevention)
• Treat sleep disorders
• Follow a heart-healthy diet pattern such as the Mediterranean or MIND diet
• Do not smoke and limit alcohol

These measures also improve overall health even if they do not completely prevent dementia.

Diagnosis involves a comprehensive evaluation:

• Detailed medical and family history
• Physical and neurologic examination
• Cognitive and neuropsychological testing
• Blood tests to rule out reversible causes (thyroid disease, vitamin B12 deficiency, infections, etc.)
• Brain imaging (MRI or CT) to look for atrophy patterns or other pathology
• In selected cases, PET imaging for amyloid or tau, or cerebrospinal-fluid analysis for biomarkers
• Newer blood tests for Alzheimer’s biomarkers are becoming available and may simplify diagnosis in the future

A diagnosis of probable Alzheimer’s disease can be made with high confidence in specialized settings; definitive confirmation still requires autopsy in most cases, although biomarker-supported diagnosis is increasingly accepted.

Consult a healthcare professional if you or a loved one experiences progressive memory problems, confusion, difficulty with familiar tasks, or personality changes that interfere with daily life. Early evaluation is important because some causes of cognitive decline are reversible or treatable, and early Alzheimer’s diagnosis opens access to treatments and planning resources.

Seek urgent care for sudden confusion, rapid cognitive change, or symptoms accompanied by headache, fever, or neurological deficits, as these may indicate stroke, infection, or other emergencies.

Current treatments fall into two main categories:

Symptom-management medicines

• Cholinesterase inhibitors (donepezil, rivastigmine, galantamine) — may temporarily improve or stabilize memory and thinking in mild to moderate stages
• Memantine — used alone or with a cholinesterase inhibitor in moderate to severe stages

Disease-modifying therapies
Recent approvals of anti-amyloid monoclonal antibodies (such as lecanemab and donanemab) can modestly slow clinical decline in people with early Alzheimer’s who have confirmed amyloid pathology. These treatments require careful patient selection, MRI monitoring for side effects (ARIA), and infusion logistics. They are not cures and are not appropriate for everyone.

Non-drug approaches are equally important: cognitive stimulation, physical exercise, treatment of sleep and mood disorders, safety modifications at home, and caregiver education and support. Clinical trials remain an option for many patients.

For the person living with Alzheimer’s:

• Establish regular routines for meals, medication, and activities
• Use memory aids (calendars, labeled photos, simple written instructions)
• Stay physically, socially, and mentally active within current abilities
• Maintain good nutrition and hydration
• Create a safe home environment (remove tripping hazards, install locks or alarms if wandering is a risk)

For caregivers:

• Learn about the disease and available resources
• Join support groups or seek counseling
• Take breaks and accept help from others
• Attend to your own health and legal/financial planning early

When seeking evaluation for memory or thinking concerns:

• Write down specific examples of memory or functional problems and when they began
• List all medicines, supplements, and recent illnesses
• Bring a knowledgeable family member or friend who can provide additional history
• Note any family history of dementia
• Prepare questions about diagnosis, treatment options, clinical trials, driving safety, and future planning
• Ask about referral to a memory-care specialist or Alzheimer’s Disease Research Center if appropriate

Early, thorough evaluation gives the best chance to identify treatable factors and access emerging therapies.